Farrah has an Mbio from the University of Warwick, where she focused her research on immunology. During her Master’s, she worked for an industry leader in pharmaceutical manufacturing in the bioassay branch, which helps inform her role as the lead researcher for gene therapy. She has curated numerous pieces of work as part of her role, including a thought-piece on the impact of clinical holds within the AAV space. She strives to maintain a high quality module by keeping an eye on the newest platform technologies, delivery systems and target organs, as well as the financial news within the space.